Literature DB >> 27604827

TGF-β Effects on Prostate Cancer Cell Migration and Invasion Require FosB.

Cachétne S X Barrett1, Ana C Millena1, Shafiq A Khan1.   

Abstract

BACKGROUND: Activator Protein-1 (AP-1) family (cJun, JunB, JunD, cFos, FosB, Fra1, and Fra2) plays a central role in the transcriptional regulation of many genes that are associated with cell proliferation, differentiation, migration, metastasis, and survival. Many oncogenic signaling pathways converge at the AP-1 transcription complex. Transforming growth factor beta (TGF-β) is a multifunctional regulatory cytokine that regulates many aspects of cellular function, including cellular proliferation, differentiation, migration, apoptosis, adhesion, angiogenesis, immune surveillance, and survival.
METHODS: This study investigated, the role of FOS proteins in TGF-β signaling in prostate cancer cell proliferation, migration, and invasion. Steady state expression levels of FOS mRNA and proteins were determined using RT-PCR and western blotting analyses. DU145 and PC3 prostate cancer cells were exposed to TGF-β1 at varying time and dosage, RT-PCR, western blot, and immunofluorescence analyses were used to determine TGF-β1 effect on FOS mRNA and protein expression levels as well as FosB subcellular localization. Transient silencing of FosB protein was used to determine its role in cell proliferation, migration, and invasion.
RESULTS: Our data show that FOS mRNA and proteins were differentially expressed in human prostate epithelial (RWPE-1) and prostate cancer cell lines (LNCaP, DU145, and PC3). TGF-β1 induced the expression of FosB at both the mRNA and protein levels in DU145 and PC3 cells, whereas cFos and Fra1 were unaffected. Immunofluorescence analysis showed an increase in the accumulation of FosB protein in the nucleus of PC3 cells after treatment with exogenous TGF-β1. Selective knockdown of endogenous FosB by specific siRNA did not have any effect on cell proliferation in PC3 and DU145 cells. However, basal and TGF-β1- and EGF-induced cell migration was significantly reduced in DU145 and PC3 cells lacking endogenous FosB. TGF-β1- and EGF-induced cell invasion were also significantly decreased after FosB knockdown in PC3 cells.
CONCLUSION: Our data suggest that FosB is required for migration and invasion in prostate cancer cells. We also conclude that TGF-β1 effect on prostate cancer cell migration and invasion may be mediated through the induction of FosB. Prostate 77:72-81, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  AP-1; FosB; TGF-β; cell invasion; cell migration; prostate cancer

Mesh:

Substances:

Year:  2016        PMID: 27604827      PMCID: PMC5286811          DOI: 10.1002/pros.23250

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  39 in total

Review 1.  Drug resistance in castration resistant prostate cancer: resistance mechanisms and emerging treatment strategies.

Authors:  Cameron M Armstrong; Allen C Gao
Journal:  Am J Clin Exp Urol       Date:  2015-08-08

2.  Differentiation plasticity regulated by TGF-beta family proteins in development and disease.

Authors:  Rik Derynck; Rosemary J Akhurst
Journal:  Nat Cell Biol       Date:  2007-09       Impact factor: 28.824

Review 3.  AP-1 in mouse development and tumorigenesis.

Authors:  W Jochum; E Passegué; E F Wagner
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

Review 4.  Variety in the level of gene control in eukaryotic cells.

Authors:  J E Darnell
Journal:  Nature       Date:  1982-06-03       Impact factor: 49.962

Review 5.  AP-1 as a regulator of cell life and death.

Authors:  Eitan Shaulian; Michael Karin
Journal:  Nat Cell Biol       Date:  2002-05       Impact factor: 28.824

6.  FosB is highly expressed in normal mammary epithelia, but down-regulated in poorly differentiated breast carcinomas.

Authors:  Karin Milde-Langosch; Holger Kappes; Sabine Riethdorf; Thomas Löning; Ana-Maria Bamberger
Journal:  Breast Cancer Res Treat       Date:  2003-02       Impact factor: 4.872

7.  Autocrine regulation of steroidogenic function of Leydig cells by transforming growth factor-alpha.

Authors:  Ana Cecilia Millena; Sheila C Reddy; Gretchen H Bowling; Shafiq A Khan
Journal:  Mol Cell Endocrinol       Date:  2004-09-30       Impact factor: 4.102

8.  Characterization of type I receptors for transforming growth factor-beta and activin.

Authors:  P ten Dijke; H Yamashita; H Ichijo; P Franzén; M Laiho; K Miyazono; C H Heldin
Journal:  Science       Date:  1994-04-01       Impact factor: 47.728

9.  TGF-β effects on prostate cancer cell migration and invasion are mediated by PGE2 through activation of PI3K/AKT/mTOR pathway.

Authors:  Baohan T Vo; Derrick Morton; Shravan Komaragiri; Ana C Millena; Chelesie Leath; Shafiq A Khan
Journal:  Endocrinology       Date:  2013-03-20       Impact factor: 4.736

10.  Signaling activity of transforming growth factor beta type II receptors lacking specific domains in the cytoplasmic region.

Authors:  R Wieser; L Attisano; J L Wrana; J Massagué
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

View more
  27 in total

1.  Essential role of JunD in cell proliferation is mediated via MYC signaling in prostate cancer cells.

Authors:  Bethtrice Elliott; Ana Cecilia Millena; Lilya Matyunina; Mengnan Zhang; Jin Zou; Guangdi Wang; Qiang Zhang; Nathan Bowen; Vanessa Eaton; Gabrielle Webb; Shadyra Thompson; John McDonald; Shafiq Khan
Journal:  Cancer Lett       Date:  2019-02-11       Impact factor: 8.679

2.  Genetic Ancestry Analysis Reveals Misclassification of Commonly Used Cancer Cell Lines.

Authors:  Stanley E Hooker; Leanne Woods-Burnham; K Sean Kimbro; Rick A Kittles; Madhavi Bathina; Stacy Lloyd; Priyatham Gorjala; Ranjana Mitra; Larisa Nonn
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-02-20       Impact factor: 4.254

3.  Differential Actions of Estrogen Receptor α and β via Nongenomic Signaling in Human Prostate Stem and Progenitor Cells.

Authors:  Shyama Majumdar; Jaqueline C Rinaldi; Neha R Malhotra; Lishi Xie; Dan-Ping Hu; Timothy D Gauntner; Harinder S Grewal; Wen-Yang Hu; Sung Hoon Kim; John A Katzenellenbogen; Susan Kasper; Gail S Prins
Journal:  Endocrinology       Date:  2019-11-01       Impact factor: 4.736

Review 4.  The functional multipotency of transforming growth factor β signaling at the intersection of senescence and cancer.

Authors:  Justyna Mikuła-Pietrasik; Szymon Rutecki; Krzysztof Książek
Journal:  Cell Mol Life Sci       Date:  2022-03-19       Impact factor: 9.261

5.  RacGAP1 promotes the malignant progression of cervical cancer by regulating AP-1 via miR-192 and p-JNK.

Authors:  Tianli Zhang; Chunyan Wang; Kun Wang; Ying Liang; Ting Liu; Liping Feng; Xingsheng Yang
Journal:  Cell Death Dis       Date:  2022-07-12       Impact factor: 9.685

6.  Apolipoprotein D as a Potential Biomarker and Construction of a Transcriptional Regulatory-Immune Network Associated with Osteoarthritis by Weighted Gene Coexpression Network Analysis.

Authors:  Yong Qin; Jia Li; Yonggang Zhou; Chengliang Yin; Yi Li; Ming Chen; Yinqiao Du; Tiejian Li; Jinglong Yan
Journal:  Cartilage       Date:  2021-10-31       Impact factor: 3.117

7.  Differential role of PTEN in transforming growth factor β (TGF-β) effects on proliferation and migration in prostate cancer cells.

Authors:  Mawiyah N Kimbrough-Allah; Ana C Millena; Shafiq A Khan
Journal:  Prostate       Date:  2018-01-16       Impact factor: 4.104

8.  Effective Cancer Subtype and Stage Prediction via Dropfeature-DNNs.

Authors:  Zhong Chen; Wensheng Zhang; Hongwen Deng; Kun Zhang
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2022-02-03       Impact factor: 3.710

9.  An Adaptogen: Withaferin A Ameliorates in Vitro and in Vivo Pulmonary Fibrosis by Modulating the Interplay of Fibrotic, Matricelluar Proteins, and Cytokines.

Authors:  Swarna Bale; Pooladanda Venkatesh; Manoj Sunkoju; Chandraiah Godugu
Journal:  Front Pharmacol       Date:  2018-03-22       Impact factor: 5.810

10.  RNA-seq transcriptome analysis of formalin fixed, paraffin-embedded canine meningioma.

Authors:  Jennifer K Grenier; Polly A Foureman; Erica A Sloma; Andrew D Miller
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.